Suvoda is proud to sponsor and present at CBI's 2nd Annual Direct-to-Patient Clinical Trials. This conference provides a unique opportunity to collaborate with industry pioneers through a mix of real-world examples, interactive discussions and engaging panels to navigate this emerging landscape and successfully enable direct-to-patient trials.
Suvoda will be co-presenting with Bellerophon Therapeutics, discussing how the right IRT system can help simplify and streamline the complexity of Direct-to-Patient clinical trials.
Case Study: Managing a Successful Direct-to-Patient Clinical Trial Using IRT
Thursday, August 8, 2019
2:40 pm EST
Lisa Killi, Director of Clinical Supplies Management, Bellerophon
Shivanni Sukha, Technical Consultant, Services, Suvoda
Conference Insights and Takeaways:
- Assess key factors to determine when a virtual, hybrid or traditional model is the best fit for a clinical trial
- Identify unexpected challenges to recruitment and
conduct in a siteless trial - Evaluate, implement and maintain new technology
- Break down current CTTI and FDA guidance documents on decentralized trials
- Restructure traditional supply chains to adapt to
siteless models - Partner with home healthcare providers to enable
virtual and hybrid trials
Register Here
8-9 August 2019
Philadelphia, PA